Showing results (101-110 of 155) with videos related to

Sort By:
Pageof 16
Vaccine|January 16, 2021
Synergistic effect of GRA7 and profilin proteins in vaccination against chronic Toxoplasma gondii infectionNadia Arcon, Mariano S Picchio, Ignacio M Fenoy, et al.
Kidney International Reports|May 14, 2023
OVERTURE: A Worldwide, Prospective, Observational Study of Disease Characteristics in Patients With ADPKDRonald D Perrone, Dorothee Oberdhan, John Ouyang, et al.
Kidney International Reports|November 17, 2017
Prognostic Enrichment Design in Clinical Trials for Autosomal Dominant Polycystic Kidney Disease: The TEMPO 3:4 Clinical TrialMaria V Irazabal, Jaime D Blais, Ronald D Perrone, et al.
Kidney International|June 29, 2021
Primary results of the randomized trial of metformin administration in polycystic kidney disease (TAME PKD)Ronald D Perrone, Kaleab Z Abebe, Terry J Watnick, et al.
Kidney International|March 23, 2019
Plasma copeptin levels predict disease progression and tolvaptan efficacy in autosomal dominant polycystic kidney diseaseRon T Gansevoort, Maatje D A van Gastel, Arlene B Chapman, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 22, 2011
Rationale and design of the TEMPO (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and its Outcomes) 3-4 StudyVicente E Torres, Esther Meijer, Kyongtae T Bae, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 12, 2020
Toward Patient-Centered Innovation: A Conceptual Framework for Patient-Reported Outcome Measures for Transformative Kidney Replacement DevicesJennifer E Flythe, Tandrea S Hilliard, Kourtney Ikeler, et al.
Plos One|October 27, 2017
Toxoplasma gondii serine-protease inhibitor-1: A new adjuvant candidate for asthma therapyAriadna S Soto, Ignacio M Fenoy, Vanesa R Sanchez, et al.
Pageof 16